AD is pathologically characterized by amyloid-beta (Aβ) plaques and tau pathology (neurofibrillary tangles) which can be detected with Aβ positron emission tomography (PET) scans and used to differentiate AD from other forms of dementia. The gene discussed is MAPT; the disease is Alzheimer disease.